Searchable abstracts of presentations at key conferences in endocrinology

ea0084op-09-42 | Oral Session 9: Thyroid Cancer Clinical | ETA2022

Childhood papillary thyroid carcinoma: long-term postoperative outcome and prediction of recurrent disease in 189 patients consecutively treated at the mayo clinic during 1936 through 2020

Hay Ian , Kaggal Suneetha , Rivera Michael , Pittock Siobhan , Thompson Geoffrey

Objectives: Childhood papillary thyroid cancer (CPTC) often presents with advanced disease but rarely results in cause-specific mortality (CSM). Controversy remains regarding optimal management and association with non-thyroid second primary malignancies (NSPM). We analyzed outcome in 189 CPTC patients and assessed the influence of radioiodine remnant ablation (RRA) and the utility of the American Thyroid Association risk-groups (ATA-R) in predicting tumor recurrence (TR)....

ea0086op6.4 | Endocrine Cancer and Late Effects | SFEBES2022

Endocrinopathies in cancer patients receiving immune checkpoint inhibitors are associated with an improved overall survival

Murthy Sruthi , Mahmoud Sarah , Gonzalez Michael A , Martin Niamh M

Background: Immune checkpoint inhibitors (ICIs) including programmed-death cell-1 (PD-1), programmed death-ligand 1 (PD-L1) and cytotoxic T-lymphocyte antigen-4 (CTLA-4) re-activate T lymphocytes and promote cancer cell death. Immune-related adverse events (irAEs) are common in cancer patients receiving ICIs. Endocrine irAEs include primary thyroid dysfunction, hypophysitis, type 1 diabetes mellitus (T1DM) and primary adrenal insufficiency. These endocrinopathies may require a...

ea0086p59 | Metabolism, Obesity and Diabetes | SFEBES2022

The role of glucocorticoid activation by 11bHSD1 for muscle wasting in a mouse model of renal impairment

Sagmeister Michael , Crastin Ana , Jones Simon , Harper Lorraine , Hardy Rowan

Background: Chronic kidney disease aggravates loss of skeletal muscles mass and function, which is an independent risk factor for hospitalisation, morbidity and mortality. Glucocorticoid signalling has been implicated as a critical factor in the pathogenesis of muscle atrophy in kidney disease. This study tests whether genetic deletion of the glucocorticoid-activating enzyme 11beta-hydroxysteroid dehydrogenase type 1 (11bHSD1) protects against muscle atrophy in the adenine-die...

ea0086p228 | Metabolism, Obesity and Diabetes | SFEBES2022

Self-care pattern in patient living with type 2 diabetes Southwest, Nigeria

Enikuomehin Adenike , Olamoyegun Michael , Ala Olubukola , Ojo Olubukola , Ajani David

Background: Self-care practices in patient living with diabetes are important to effectively prevent, manage, and limit complications associated with diabetes as patients spend more time alone than they spent with health care providers in managing their health conditions.Aims: The aim of the study was to evaluate self-cate practices and their determinants in patients living with type 2 diabetes. Hence, this study aimed at assessing self-care practices an...

ea0086p339 | Metabolism, Obesity and Diabetes | SFEBES2022

Diabetic striatopathy: A rare presentation as stroke mimic and focal seizure

Thayyil Sheena , Macriyiannis Thrasos , Philips Michael , Vimal Venugopalprabhu

Introduction: Diabetes striatopathy (DS) is an extremely rare hyperglycaemic complication of diabetes with a prevalence reported as 1 in 100,0001. Though DS is commonly associated with a non-ketotic hyperglycaemic hyperosmolar state (HHS), it is occasionally reported in diabetic ketoacidosis (DKA). DS is known as non-ketotic hemichorea-hemiballismus due to its presentation with hyperkinetic movements but rarely presents as stroke-mimic2. Here we present a...

ea0086p105 | Neuroendocrinology and Pituitary | SFEBES2022

Case Series: Primary / neo-adjuvant 131I-MIBG therapy as a safe and effect treatment in the management of pheochromocytoma / paraganglioma

Onyema Michael , Crane James , Reynolds Saira , Whitelaw Benjamin

Background: As per 2014 Endocrine Society guidelines, 131I-MIBG therapy is usually reserved for metastatic or unresectable disease in patients with pheochromocytoma / paraganglioma. In this series, we describe three patients effectively treated with primary 131I-MIBG therapy. The indications were primary neo-adjuvant therapy prior to surgery, or palliative.Case series: Case 1 – 18-year-old male with a 60 mm para-aortic paragang...

ea0086p362 | Reproductive Endocrinology | SFEBES2022

Clinical utility of GnRH analogues in female androgen excess: diagnostic and therapeutic implications

Madden Doyle Lauren , Cussen Leanne , McDonnell Tara , O'Reilly Michael W

Rare causes of severe androgen excess (AE) can present a diagnostic challenge to endocrinologists. Imaging may not identify occult ovarian pathology, and the detection of adrenal nodular disease may be indicative of incidental pathology. GnRH analogues can be used both as a medical treatment and as a diagnostic utility to confirm ovarian source, particularly in women with a preferential elevation of serum testosterone (T). In this case series, we present three cases highlighti...

ea0090ep607 | Endocrine-related Cancer | ECE2023

Extra-adrenal adrenocortical cancer (ACC) associated with multiple endocrine neoplasia type 1

Green Deirdre , Thompson Chris , Hill Arnold , O'Reilly Michael , Sherlock Mark

Adrenocortical carcinoma (ACC) is a rare malignant tumour arising from the adrenal cortex, with an estimated annual incidence of one to two patients per million. Ectopic ACCs are extremely rare. They are believed to arise from cortical fragments arrested during embryologic migration and have been found close to the adrenal gland or along the path of gonadal descent. The majority of ACCs are sporadic, however, ACC has been linked with genetic disease processes, including multip...

ea0091wd9 | Workshop D: Disorders of the adrenal gland | SFEEU2023

White hair and loss of eyebrows: An unusual presentation of ACC

Thurston Layla , Di Marco Aimee , Seckl Michael , Wernig Florian

A 57-year-old gentleman presented with a very sudden change in hair colour to bright white and eyebrow loss. On further questioning, he had been shaving much less and had not been getting any erections. On examination he had gynaecomastia. Initial blood tests showed hypogonadotrophic hypogonadism (LH 0.6 IU/l, FSH 0.1 IU/l, testosterone 1.6 nmol/l) with an otherwise normal anterior pituitary hormonal profile. Oestradiol was found to be significantly elevated at 582 pmol/l. He ...

ea0069p15 | Poster Presentations | SFENCC2020

‘Tiger Woman Sign’; Hypercalcaemia Secondary to Atypical Isolated Sarcoid Myositis

Muse Adam , Evans Michael , Cates Matthew , Walker Jonathan Neil

Section 1: Case history: A 57-year-old female shop assistant presented with a four week history of increasing thirst and lethargy. The patient also reported non-specific pain in her shoulders, ribs and hips. She was otherwise well with no past medical history. Systemic enquiry was unremarkable. On examination nothing abnormal was noted. Specifically there were no rashes, lymphadenopathy or hepatosplenomegaly. Joint examination was normal and there was no muscle tenderness or w...